Immunocore Holdings (IMCR) Operating Income (2023 - 2025)
Historic Operating Income for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$7.2 million.
- Immunocore Holdings' Operating Income rose 1565.51% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.1 million, marking a year-over-year increase of 3371.53%. This contributed to the annual value of -$70.5 million for FY2024, which is 1812.6% down from last year.
- Per Immunocore Holdings' latest filing, its Operating Income stood at -$7.2 million for Q3 2025, which was up 1565.51% from -$14.9 million recorded in Q2 2025.
- Immunocore Holdings' Operating Income's 5-year high stood at -$3.6 million during Q1 2025, with a 5-year trough of -$51.1 million in Q4 2021.
- In the last 5 years, Immunocore Holdings' Operating Income had a median value of -$15.4 million in 2024 and averaged -$20.8 million.
- As far as peak fluctuations go, Immunocore Holdings' Operating Income tumbled by 8025.31% in 2024, and later skyrocketed by 8634.96% in 2025.
- Quarter analysis of 5 years shows Immunocore Holdings' Operating Income stood at -$51.1 million in 2021, then surged by 36.43% to -$32.5 million in 2022, then skyrocketed by 47.48% to -$17.1 million in 2023, then dropped by 14.07% to -$19.5 million in 2024, then surged by 63.13% to -$7.2 million in 2025.
- Its Operating Income stands at -$7.2 million for Q3 2025, versus -$14.9 million for Q2 2025 and -$3.6 million for Q1 2025.